NASDAQ:CELZ Creative Medical Technology (CELZ) Stock Forecast, Price & News $4.73 -0.02 (-0.42%) (As of 11:48 AM ET) Add Compare Share Share Today's Range$4.71▼$4.8550-Day Range$4.23▼$6.1652-Week Range$3.30▼$14.20Volume2,310 shsAverage Volume175,464 shsMarket Capitalization$6.67 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Creative Medical Technology (NASDAQ:CELZ) StockCreative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.Read More CELZ Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CELZ Stock News HeadlinesSeptember 22, 2023 | finance.yahoo.comWhat Makes Creative Medical Technology Holdings, Inc. (CELZ) a New Buy StockSeptember 19, 2023 | finance.yahoo.comCreative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back PainOctober 4, 2023 | Behind the Markets (Ad)[BREAKING] New "Living Missile" to Replace Nuclear MissilesCBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!August 24, 2023 | finance.yahoo.comWhat Is Allogeneic Cell Therapy, And What’s Driving This Market’s 25%+ Annual Global Growth?August 23, 2023 | benzinga.comWhat Is Allogeneic Cell Therapy, And What's Driving This Market's 25%+ Annual Global Growth?June 28, 2023 | msn.comCreative Medical Technology regains Nasdaq listing complianceJune 12, 2023 | finance.yahoo.comCreative Medical Technology Holdings Provides Corporate UpdateJune 12, 2023 | finance.yahoo.comCreative Medical Technology Announces $2 Million Share Repurchase ProgramOctober 4, 2023 | Behind the Markets (Ad)[BREAKING] New "Living Missile" to Replace Nuclear MissilesCBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!June 9, 2023 | msn.comCreative Medical Technology Holdings announces reverse stock split to regain complianceMay 31, 2023 | finance.yahoo.comCreative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immunotherapy PlatformMay 18, 2023 | msn.comCreative Medical Releases Data From StemSpine Procedure For Chronic Lower Back PainMay 18, 2023 | finance.yahoo.comCreative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell LineMay 14, 2023 | finance.yahoo.comCreative Medical Technology Holdings First Quarter 2023 Earnings: US$0.075 loss per share (vs US$0.18 loss in 1Q 2022)April 13, 2023 | msn.comCreative Medical (CELZ) Up 86% on Upbeat Diabetes Study DataApril 12, 2023 | msn.comCreative Medical Technology Soars after Positive Drug DataApril 12, 2023 | benzinga.comThinking about buying stock in Newmark Group, Exscientia, Pardes Biosciences, Creative Medical Technology, or Somalogic?April 12, 2023 | msn.comWhy Is Creative Medical Technology Stock Skyrocketing Today?April 4, 2023 | finance.yahoo.comCreative Medical Technology Holdings Announces Filing of 2022 Form 10-K and Provides Business UpdateMarch 23, 2023 | msn.comCreative Medical stock rises on seeking FDA orphan drug status for Brittle diabetes therapyMarch 23, 2023 | finance.yahoo.comCreative Medical Technology Files Orphan Drug Designation Application with the U.S. FDA Using the ImmCelz® Platform for the Treatment of Brittle Type 1 DiabetesMarch 21, 2023 | finance.yahoo.comCreative Medical Technology Holdings Announces Key Milestones Regarding ImmCelz® Platform DevelopmentMarch 7, 2023 | finance.yahoo.comCreative Medical Technology Holdings Engages Highly Respected International CRO for Phase 1 / 2 Clinical Trial to Treat Type 1 Diabetes Using CELZ-201February 14, 2023 | finance.yahoo.comThree Year Follow-Up Results Confirm Efficacy of StemSpine® Procedure for Treating Chronic Lower Back Pain, with No Serious Adverse EffectsFebruary 8, 2023 | benzinga.comThinking about buying stock in Creative Medical, Meta, Advanced Micro Devices, Carvana, or SeqLL?February 8, 2023 | marketwatch.comCreative Medical Technology Shares Double After Approval to Continue Clinical TrialFebruary 8, 2023 | msn.comCELZ More Than Doubles on Greenlight for Diabetes Therapy TrialSee More Headlines Receive CELZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Creative Medical Technology and its competitors with MarketBeat's FREE daily newsletter. Email Address CELZ Company Calendar Last Earnings8/11/2023Today10/04/2023Next Earnings (Estimated)11/10/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CELZ CUSIPN/A CIK1187953 Webwww.creativemedicaltechnology.com Phone(833) 336-7636FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,140,000.00 Net MarginsN/A Pretax Margin-12,637.84% Return on Equity-56.26% Return on Assets-52.68% Debt Debt-to-Equity RatioN/A Current Ratio34.42 Quick Ratio34.40 Sales & Book Value Annual Sales$90,000.00 Price / Sales74.42 Cash FlowN/A Price / Cash FlowN/A Book Value$11.27 per share Price / Book0.42Miscellaneous Outstanding Shares1,410,000Free Float1,369,000Market Cap$6.70 million OptionableNot Optionable Beta2.47 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Timothy Warbington (Age 61)Co-Founder, Chairman, Pres & CEO Comp: $429kMr. Donald Dickerson (Age 58)Sr. VP, CFO & Director Comp: $390kKey CompetitorsBrickell BiotechNASDAQ:BBITitan PharmaceuticalsNASDAQ:TTNPInhibikase TherapeuticsNYSE:IKTFresh Tracks TherapeuticsNASDAQ:FRTXFinch Therapeutics GroupNASDAQ:FNCHView All CompetitorsInsidersTimothy WarbingtonBought 800 shares on 6/27/2023Total: $3,552.00 ($4.44/share)Timothy WarbingtonBought 1,500 shares on 11/21/2022Total: $6,000.00 ($4.00/share)View All Insider Transactions CELZ Stock - Frequently Asked Questions How have CELZ shares performed in 2023? Creative Medical Technology's stock was trading at $3.8110 at the beginning of the year. Since then, CELZ shares have increased by 24.6% and is now trading at $4.75. View the best growth stocks for 2023 here. Are investors shorting Creative Medical Technology? Creative Medical Technology saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 89,800 shares, an increase of 297.3% from the August 31st total of 22,600 shares. Based on an average trading volume of 55,300 shares, the days-to-cover ratio is presently 1.6 days. Currently, 6.4% of the shares of the company are short sold. View Creative Medical Technology's Short Interest. When is Creative Medical Technology's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, November 10th 2023. View our CELZ earnings forecast. How were Creative Medical Technology's earnings last quarter? Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) released its earnings results on Friday, August, 11th. The company reported ($0.78) EPS for the quarter, topping analysts' consensus estimates of ($0.83) by $0.05. When did Creative Medical Technology's stock split? Creative Medical Technology shares reverse split before market open on Sunday, June 11th 2023. The 1-10 reverse split was announced on Sunday, June 11th 2023. The number of shares owned by shareholders was adjusted after the market closes on Sunday, June 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What is Creative Medical Technology's stock symbol? Creative Medical Technology trades on the NASDAQ under the ticker symbol "CELZ." How do I buy shares of Creative Medical Technology? Shares of CELZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Creative Medical Technology's stock price today? One share of CELZ stock can currently be purchased for approximately $4.75. How much money does Creative Medical Technology make? Creative Medical Technology (NASDAQ:CELZ) has a market capitalization of $6.70 million and generates $90,000.00 in revenue each year. How can I contact Creative Medical Technology? Creative Medical Technology's mailing address is 2017 W Peoria Ave, PHOENIX, AZ 85029-4916, United States. The official website for the company is www.creativemedicaltechnology.com. The company can be reached via phone at (833) 336-7636 or via email at kahl@equityny.com. This page (NASDAQ:CELZ) was last updated on 10/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.